Literature DB >> 25098578

The soft tissue landmarks to avoid injury to the facial artery during filler and neurotoxin injection at the nasolabial region.

Thirawass Phumyoo1, Tanvaa Tansatit, Natthida Rachkeaw.   

Abstract

The aim of this study was to locate the course of the facial artery and to propose "the danger line" vulnerable to vascular complications following filler injection. The entire facial soft tissues were harvested from 14 Thai soft embalmed cadavers as a facial flap specimen. Measurements of the distance, the depth, and the diameter of the facial artery were done at level of the oral commissure and the nasal ala. The distance between the facial artery and the oral commissure was 15.3 ± 3.7 mm and the depth from the skin was 11.1 ± 3.1 mm. The distance between the facial artery and the nasal ala was 6.7 ± 4.4 mm and the depth was 11.6 ± 3.7 mm. The diameters of the facial artery at level of the oral commissure and the nasal ala were 2.6 ± 0.8 and 1.9 ± 0.5 mm, respectively. Maximum risk of arterial complication from dermal filler injection lateral to the oral commissure is located approximately 15 mm at the depth of 11 mm. High risk of arterial injury at the lateral nasal ala is located at 7 mm with the depth of 12 mm.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25098578     DOI: 10.1097/SCS.0000000000001003

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  2 in total

Review 1.  Sustained attractiveness and natural youthful appearance by upper lip rejuvenation : Minimally invasive procedures to combat facial aging.

Authors:  Uwe Wollina; Alberto Goldman
Journal:  Wien Med Wochenschr       Date:  2017-04-05

2.  Variant facial artery anatomy revisited: Conventional angiography performed in 284 cases.

Authors:  Seok Jin Hong; Sung Eun Park; Jeong Won Jo; Do Seon Jeong; Dae Seob Choi; Jung Ho Won; Minhee Hwang; Chi Yeon Kim
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.